US drugmakers threaten to withhold products from Europe over prices
Pharmaceutical companies seek to make up any lost revenue after striking deals with Donald Trump to lower costs in US
Related reading
Healthcare companies set for deals spree as drug patents expire
A gathering of pharmaceutical executives comes as the sector has rebounded from uncertainty over Trump’s policies
Europe races to placate pharma as Donald Trump turns up the pressure
Tariff deals with the US have bought time but investment momentum is elsewhere
US pharma price probe raises threat of new drug tariffs
Trump administration plans trade assault in attempt to drive down cost of medicines including weight-loss pills
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
Europe is risking ‘health sovereignty’ by underpaying for drugs, says…
CEO warns continent’s advantage in the industry could fade as companies build new high-tech factories elsewhere